Form 4 for TWST Twist Bioscience Corp
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0001214659-22-014161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-23 | 2022-11-21 | TWST | BARTHELEMY NICOLAS | Dir | M - OptEx | $23.33 | +9,082 | 23.0K | +65% | +$211.9K |
| D | 2022-11-23 | 2022-11-21 | TWST | BARTHELEMY NICOLAS | Dir | M - OptEx | $0.00 | -9,082 | 11.3K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-21 | M | A | 9,082 | $23.33 | 23,021 | D | — | — | |
| 2 | Derivative | Director Stock Option (right to buy) | 2022-11-21 | M | D | 9,082 | $0.00 | 11,279 | D | $23.33 · — to 2029-10-23 | 9,082 Common Stock | (F1) 1/3 of the shares subject to the option vest and become exercisable on the first anniversary of October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |